DK216589A - DNA SEQUENCES, RECOMBINANT DNA MOLECULES, AND PROCEDURES FOR PROMOTING SOLUBLE T4 PROTEINS - Google Patents

DNA SEQUENCES, RECOMBINANT DNA MOLECULES, AND PROCEDURES FOR PROMOTING SOLUBLE T4 PROTEINS Download PDF

Info

Publication number: DK216589A
Authority: DK; Denmark
Prior art keywords: proteins; procedures; recombinant dna; dna sequences; dna molecules
Prior art date: 1987-09-04

Application number

DK216589A

Other languages

Danish (da)

Other versions

DK216589D0 (en

Inventor

Richard A Fischer

Walter Gilbert

Vicki L Sato

Richard A Flavell

John M Maraganore

Theresa R Liu

Original Assignee

Biogen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-09-04

Filing date

1989-05-03

Publication date

1989-07-04

1989-05-03 Application filed by Biogen Inc filed Critical Biogen Inc

1989-05-03 Publication of DK216589D0 publication Critical patent/DK216589D0/en

1989-07-04 Publication of DK216589A publication Critical patent/DK216589A/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70514—CD4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15051—Methods of production or purification of viral material

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Zoology (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Microbiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Urology & Nephrology (AREA)
Cell Biology (AREA)
Hematology (AREA)
Veterinary Medicine (AREA)
Biophysics (AREA)
Analytical Chemistry (AREA)
Food Science & Technology (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Transplantation (AREA)
General Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Physics & Mathematics (AREA)
Toxicology (AREA)
General Physics & Mathematics (AREA)

DK216589A 1987-09-04 1989-05-03 DNA SEQUENCES, RECOMBINANT DNA MOLECULES, AND PROCEDURES FOR PROMOTING SOLUBLE T4 PROTEINS DK216589A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US9432287A	1987-09-04	1987-09-04
US14164988A	1988-01-07	1988-01-07
PCT/US1988/002940 WO1989001940A1 (en)	1987-09-04	1988-09-01	Dna sequences, recombinant dna molecules and processes for producing soluble t4 proteins

Publications (2)

Publication Number	Publication Date
DK216589D0 DK216589D0 (en)	1989-05-03
DK216589A true DK216589A (en)	1989-07-04

Family

ID=26788733

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK216589A DK216589A (en)	1987-09-04	1989-05-03	DNA SEQUENCES, RECOMBINANT DNA MOLECULES, AND PROCEDURES FOR PROMOTING SOLUBLE T4 PROTEINS

Country Status (12)

Country	Link
EP (1)	EP0347435A4 (en)
JP (1)	JPH02501192A (en)
KR (1)	KR890701605A (en)
DK (1)	DK216589A (en)
ES (1)	ES2013346A6 (en)
GR (1)	GR1000489B (en)
IL (1)	IL87647A0 (en)
NO (1)	NO891818L (en)
NZ (1)	NZ226040A (en)
OA (1)	OA09625A (en)
PT (1)	PT88425B (en)
WO (1)	WO1989001940A1 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5958678A (en) *	1986-08-21	1999-09-28	The Trustees Of Columbia University In The City Of New York	DNA encoding the T cell surface protein T4 and use of fragments of T4 in the treatment of AIDS
DE3751751T2 (en)	1986-08-21	1996-10-17	Univ Columbia	DNA ENCODING THE T CELL SURFACE PROTEIN T4 AND USE OF T4 FRAGMENTS IN THE TREATMENT OF AIDS
US5336603A (en) *	1987-10-02	1994-08-09	Genentech, Inc.	CD4 adheson variants
US6710169B2 (en)	1987-10-02	2004-03-23	Genentech, Inc.	Adheson variants
ZA887365B (en) *	1987-10-02	1990-05-30	Genentech Inc	Adheson variants
US6004781A (en) *	1988-01-22	1999-12-21	The General Hospital Corporation	Nucleic acid encoding Ig-CD4 fusion proteins
PT89484B (en) *	1988-01-22	1994-03-31	Gen Hospital Corp	GENE CLONED CODES OF FUSAO PROTEINS IG-CD4 AND ITS UTILIZATION
AU3006789A (en) *	1988-02-24	1989-08-24	Smithkline Beckman Corporation	Expression of hiv binding proteins
EP0346091A3 (en) *	1988-06-10	1990-09-12	Dana Farber Cancer Institute	Method of diagnosis for naturally occurring antibodies to cd4
WO1990005534A1 (en) *	1988-11-23	1990-05-31	Genentech, Inc.	Polypeptide derivatives
AU5437190A (en) *	1989-04-05	1990-11-05	Upjohn Company, The	Soluble cd4 produced in (e. coli)
EP0408372A1 (en) *	1989-07-13	1991-01-16	Smithkline Beecham Corporation	Anti-viral therapy
AU648041B2 (en) *	1989-08-23	1994-04-14	General Hospital Corporation, The	Non-human primate CD4 polypeptides, fusions thereof, DNA encoding, and uses thereof
US5180820A (en) *	1989-08-30	1993-01-19	Barde Yves Alain	Brain-derived neurotrophic factor
JPH0725794B2 (en) *	1990-03-23	1995-03-22	呉羽化学工業株式会社	Novel peptide
AU7976791A (en) *	1990-05-25	1991-12-31	Biogen, Inc.	Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection
WO1992009305A1 (en) *	1990-11-27	1992-06-11	Biogen, Inc.	Anti cd-4 antibodies blocking hiv-induced syncytia
EP0528011A4 (en)	1991-02-08	1993-06-30	Progenics Pharmaceuticals, Inc.	Cd4-gamma2 and cd4-igg2 chimeras
WO1992013559A1 (en) *	1991-02-08	1992-08-20	Progenics Pharmaceuticals, Inc.	CD4-GAMMA1 AND CD4-IgG1 CHIMERAS
US7070991B2 (en)	1991-02-08	2006-07-04	Progenics Pharmaceuticals, Inc.	Cells expressing a CD4-IgG2 chimeric heterotetramer
US5389529A (en) *	1991-06-12	1995-02-14	Regeneron Pharmaceuticals, Inc.	Modified lamβ signal sequence and processes for producing recombinant neurotrophins
GB9219562D0 (en)	1992-03-11	1992-10-28	Prendergast Kennet F	Anti-viral peptides
ATE393236T1 (en) *	1994-11-04	2008-05-15	Idexx Lab Inc	MEDIUM FOR DETECTING CERTAIN MICROBEES IN A SAMPLE
US5635363A (en) *	1995-02-28	1997-06-03	The Board Of Trustees Of The Leland Stanford Junior University	Compositions and methods for the detection, quantitation and purification of antigen-specific T cells
CA2223088A1 (en)	1995-06-07	1996-12-19	Bob Dale Brown	Novel carbamate-based cationic lipids
ES2299276T3 (en)	1998-12-31	2008-05-16	Novartis Vaccines And Diagnostics, Inc.	MODIFIED HIV ENV POLIPEPTIDES.
EP1980617A1 (en)	1998-12-31	2008-10-15	Novartis Vaccines and Diagnostics, Inc.	Improved expression of HIV polypeptides and production of virus-like particles
EP1141314A2 (en)	1998-12-31	2001-10-10	Chiron Corporation	Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US7935805B1 (en)	1998-12-31	2011-05-03	Novartis Vaccines & Diagnostics, Inc	Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
US20030194800A1 (en)	2001-08-31	2003-10-16	Megede Jan Zur	Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
EP1411770A4 (en)	2001-07-05	2006-05-10	Chiron Corp	Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US20030170614A1 (en)	2001-08-31	2003-09-11	Megede Jan Zur	Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
CN113209124B (en) *	2021-02-24	2022-04-15	四川大学	Application of DNA tetrahedron in preparation of medicines for preventing and treating type 1 diabetes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3751751T2 (en) *	1986-08-21	1996-10-17	Univ Columbia	DNA ENCODING THE T CELL SURFACE PROTEIN T4 AND USE OF T4 FRAGMENTS IN THE TREATMENT OF AIDS
IL83687A (en) *	1987-08-30	1995-03-30	Yeda Res & Dev	Pharmaceutical compositions comprising molecular decays and their use in the manufacture of said compositions
PT88641B (en) *	1987-10-02	1993-04-30	Genentech Inc	METHOD FOR PREPARING A VARIETY OF ADHESION

1988
- 1988-09-01 JP JP63507739A patent/JPH02501192A/en active Pending
- 1988-09-01 KR KR1019890700813A patent/KR890701605A/en not_active Application Discontinuation
- 1988-09-01 WO PCT/US1988/002940 patent/WO1989001940A1/en not_active Application Discontinuation
- 1988-09-01 EP EP19880908543 patent/EP0347435A4/en not_active Withdrawn
- 1988-09-01 IL IL87647A patent/IL87647A0/en unknown
- 1988-09-05 PT PT88425A patent/PT88425B/en not_active IP Right Cessation
- 1988-09-05 GR GR880100579A patent/GR1000489B/en unknown
- 1988-09-05 ES ES8802727A patent/ES2013346A6/en not_active Expired - Lifetime
- 1988-09-05 NZ NZ226040A patent/NZ226040A/en unknown
1989
- 1989-05-02 NO NO89891818A patent/NO891818L/en unknown
- 1989-05-03 DK DK216589A patent/DK216589A/en not_active Application Discontinuation
1990
- 1990-03-01 OA OA59745A patent/OA09625A/en unknown

Also Published As

Publication number	Publication date
NO891818L (en)	1989-07-03
AU626007B2 (en)	1992-07-23
EP0347435A4 (en)	1991-11-21
NZ226040A (en)	1992-02-25
KR890701605A (en)	1989-12-21
WO1989001940A1 (en)	1989-03-09
AU2482988A (en)	1989-03-31
JPH02501192A (en)	1990-04-26
GR880100579A (en)	1989-06-22
NO891818D0 (en)	1989-05-02
EP0347435A1 (en)	1989-12-27
DK216589D0 (en)	1989-05-03
GR1000489B (en)	1992-07-30
ES2013346A6 (en)	1990-05-01
PT88425B (en)	1992-10-30
IL87647A0 (en)	1989-02-28
PT88425A (en)	1989-07-31
OA09625A (en)	1993-04-30

Publication	Publication Date	Title
DK216589D0 (en)	1989-05-03	DNA SEQUENCES, RECOMBINANT DNA MOLECULES, AND PROCEDURES FOR PROMOTING SOLUBLE T4 PROTEINS
DK73483D0 (en)	1983-02-21	DNA SEQUENCES, RECOMBINANT DNA MOLECULES, AND PROCEDURES FOR MANUFACTURING HUMAN-IMMUNE INTERFERON-LIKE POLYPEPTIDES
DE68907407D1 (en)	1993-08-05	METHOD FOR SEQUENCE ANALYSIS OF DNA.
DK129588A (en)	1988-09-12	PROCEDURE FOR DETERMINING NUCLEIC ACIDS AND REAGENT COMBINATION AND
DK166087A (en)	1987-10-05	HTLV-III VIRUS PROTEIN, DNA SEQUENCE THAT CODES THEREOF, PROCEDURES FOR PRODUCING IT, PROCEDURE FOR DETECTING AIDS VIRUS AND ANTIBODIES AGAINST AIDS VIRUS
DE3585147D1 (en)	1992-02-20	METHOD FOR PURIFYING PROTEINS.
DK110885A (en)	1985-09-13	NUCLEIC ACID PROTEIN CONJUGATES, THEIR USE AND THE METHOD OF PREPARING IT
DE3881796D1 (en)	1993-07-22	SYSTEM FOR ALIGNING AND LOCKING PEN.
DK672788A (en)	1989-07-28	RECOMBINANT DNA VECTORS FOR DIRECT EXPRESSION OF ACTIVATED HUMANT PROTEIN C
DK54184D0 (en)	1984-02-07	DNA SEQUENCES, RECOMBINATION DNA MOLECULES, AND METHODS FOR HUMAN PREPARATION (INTERLEUKIN) TWO SIMILAR POLIPEPTIDES
DK38989A (en)	1989-07-29	DNA sequence
DE69005959D1 (en)	1994-02-24	Process for the purification of human serum albumin.
DK41590D0 (en)	1990-02-16	IMPROVED PROTEIN C MOLECULES AND PROCEDURES FOR THE PREPARATION AND ACTIVATION OF SAME
IL88095A0 (en)	1989-06-30	Dna sequences,proteins and gene preparations
ATE113075T1 (en)	1994-11-15	PLASMIDS AND HOST CELLS FOR THE EXPRESSION OF INA PROTEIN (ICE NUCLEATING PROTEIN).
DE3852293D1 (en)	1995-01-12	METHOD AND STRUCTURE FOR ADJUSTING REFLECTOR SURFACES.
NO905561D0 (en)	1990-12-21	PROTEINS AND NUCLEIC ACIDS.
DE3769749D1 (en)	1991-06-06	METHOD FOR OBTAINING PURIFIED AMINO ACIDS.
DK319888D0 (en)	1988-06-10	DNA fragments
DE59004279D1 (en)	1994-03-03	Process for the C-terminal modification of proteins.
DE68917769D1 (en)	1994-10-06	Process for refining amino acids.
FI873674A0 (en)	1987-08-25	-2-PLASMIN INHIBITOR LICENSE PROTEIN KODANDE DNA.
DK578189D0 (en)	1989-11-17	DNA sequence
DE69000909D1 (en)	1993-03-25	TRANSPORTABLE BRIDGE PART FOR OVERCOME DIGS.
IE882662L (en)	1989-03-04	Dna sequences, recombinant dna molecules for producing¹soluble t4 proteins

Legal Events

Date	Code	Title	Description
1994-05-24	AHB	Application shelved due to non-payment